Join us in Palm Springs, CA at CHDI's 20th Annual Huntington's Disease Therapeutics Conference (HDTC). Learn more about our involvement in the event below.
Evotec At HDTC
Poster Presentations
All poster presentations will take place on Wednesday, 26 February from 1:00 - 4:00pm
- Development of HTT exon1-selective immunoassays with novel HTT P90 C-term neo-epitope targeted antibodies
Presented by Barbara Baldo, Group Leader, Translational Biomarkers - Exploratory analysis of PENK as an early marker of HD onset and progression
Presented by Barbara Baldo, Group Leader, Translational Biomarkers - Investigation of human MutL protein complexes in the mismatch repair pathway in a frameshift mutator assay in HeLa cells to support therapeutic intervention strategies for Huntington’s Disease
Presented by Karsten Tillack, Sr. Research Scientist, Translational Biomarkers - URSA (Un-scheduled DNA Repair Synthesis Assay), a proxy for Somatic Instability (SI)?
Presented by Frank Herrmann, VP Biomarkers, Translational Biomarkers - Mouse CSF Proteomic Analysis by Mass Spectrometry Applied to Huntington’s Disease Models
Presented by Mari Aaltonen, Research Scientist, Chemical Biology - Nanoparticle-based Proteomics by Mass Spectrometry in Plasma Samples from Huntington’s Disease Cohort
Presented by Mari Aaltonen, Research Scientist, Chemical Biology - Probing HTT RNA by SHAPE to enable allele-selective targeting with small molecules
Presented by Frank Herrmann, VP Biomarkers, Translational Biomarkers
